Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREATHE: Azithromycin for HIV-associated Chronic Lung Disease
NCT02426112Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azithromycin in chronic lung disease, sponsored by London School of Hygiene & Tropical Medicine. Started Jun 2016; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic lung disease
Beyond the preview
Go deeper on NCT02426112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426112.